Senate Bill 1626 amends Tennessee law to require health plans to provide coverage for specific cancer-related services. The bill mandates that insurers include coverage for clinical genetic testing for inherited gene mutations in individuals with a personal or family history of cancer, as well as evidence-based cancer imaging for those at increased risk of cancer, in accordance with the National Comprehensive Cancer Network (NCCN) clinical practice guidelines. Importantly, the coverage for these services must not be subject to any cost-sharing requirements, such as deductibles or copayments.

Additionally, the bill addresses the implications for health savings accounts (HSAs) under federal law. It stipulates that if the application of the coverage requirements would affect HSA eligibility, the requirements will still apply to high deductible health plans after the enrollee meets the minimum deductible, except for preventive care services. The act is set to take effect on July 1, 2026, and will apply to plans issued, amended, or renewed on or after that date.